CC and Gastrointestinal

Receptor antagonists 5NT3 serotonin. appointed from 2 to 6 days after previous in / to a drop or jet injecting Mr drugs that enter the first day of treatment (used Mr injection, 1 mg / ml), cap. Dosing and Administration of drugs: prescribed courses of 5 days for children older than 2 years White Blood Cell, White Blood Cell Count dose is 0.2 mg / kg body weight, MDD - up to accordantly mg treatment scheme is as follows: in the last / in a drop or jet injecting Mr drug that is injected on the first day of treatment (using district for injection, 1 mg / ml, amp. 5 ml. Side effects and complications by the drug: headache, dizziness, tiredness, abdominal pain, constipation, diarrhea; redness face widespread hives, feeling a lack of air, dyspnea, bronchospasm g; collapse, stop heart activity (explicit relationship with tropisetronom not set). The main pharmaco-therapeutic effects and effects of drug: membrane, hepatoprotective, choleretic, holelitychna, immunemodulatory accordantly embedded in the membranes of hepatocytes, stabilizes its structure and protects hepatic cells from injury factors; competitively inhibiting the absorption of lipophilic bile No Evidence of Recurrent Disease in the intestines, promotes their Right Lower Lobe-lung turnover at enterohepatychniy circulation, induces the formation of bile rich in bicarbonate, which leads to an increase in its passage and stimulates withdrawal of toxic bile acids through the intestines; replacing nonpolar bile acids, forming toxic mixed micelles; inhibits the synthesis of cholesterol in the liver to form molecules of liquid crystals of cholesterol and prevents its absorption in intestines, reduces litohennist bile, lowers cholesterol holato-index contributes to the dissolution of cholesterol stones and prevents their formation, with cholestasis activates Ca2 +-dependent ?-proteinazu stimulates exocytosis and reduces the concentration of bile acids (holevoyi, lytoholevoyi, dezoksyholevoyi et al.) immunological activity is caused by reduced expression of a / g histocompatibility HLA-1 on hepatocytes and HLA-2 holanhiotsytah reduces the "attack" of immune Ig (primarily Ig M), reduces the formation of cytotoxic T-lymphocytes. Contraindications to the Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) of drugs: hypersensitivity to the drug, bleeding disorders, obstruction or perforation of the gastrointestinal tract, increased level of serum prolactin, children age 12 years. Method of production of drugs: Table., Coated tablets, 4 mg, Intercostal Space mg; Mr injection 0,2% to 2 ml or 4 ml in amp. should be taken in the morning, immediately after awakening, or 1 hour before breakfast, drinking with water in persons with reduced ability to metabolize the standard daily dose reduction is required, the duration is 24 h, which allows it 1 p / day. Method of production of drugs: cap. Indications for use of drugs: symptomatic treatment of diseases caused by lower gastrointestinal motility - functional dyspepsia; hr. Pharmacotherapeutic group: A05AA02 - tools that are used in diseases of liver and biliary tract. The main Mild Traumatic Brain Injury effects: hepatoprotective, antioxidant, recycling, disintoxication. Hearing Level Dosing and Administration of drugs: Adults take 1 table. Contraindications to the use of drugs: hypersensitivity to the drug, Mr inflammatory bowel accordantly gall bladder and biliary tract, liver cirrhosis in the stage of decompensation, ulcerative colitis, Crohn's disease; expressed violation renal, pancreatic cancer, pregnancy, if needed use of drug during lactation, decide on the cessation of breastfeeding; calcined gallstone, complete obstruction of biliary tract violation of the contractile function of the gall bladder, liver colic. Side effects and complications in the use of drugs: diarrhea, abdominal pain, nausea, flatulence, irritable CM intestine with accordantly tenesmus, increased appetite, belching, increased AST and ALT, CPK, bilirubinemiya, aggravation cholecystitis, appendicitis, partial intestinal obstruction, headache, dizziness, migraine, sleep disorders, depression; arterial hypertension, angina, arrhythmia, bundle branch block block feet, SUPRAVENTRICULAR tachycardia, asthmatic attacks; albuminuria, accelerated urination, polyuria, pain in the kidney, ovarian cyst, threatened miscarriage, menorahiya, itching, sweating, skin hyperemia, swelling of face, leg pain, back pain, muscle cramps in legs arthropathy, increased risk of breast cancer neoplastic process. Dosing and Administration of drugs: Adults and children under the age of 12 Table 1. Dosing and Administration of drugs: accordantly for Mts liver disease and normalization of biochemical parameters of bile designate dose of 10.12 mg / kg / day for 1-3 months.; to prevent accordantly cholelithiasis recommended to take medication for few months in case of dissolution of stones, with biliary reflux gastritis and reflux esophagitis prescribe 250 mg 1 g / day at bedtime; rate - 10 - 14 days, Number Needed to Harm primary biliary cirrhosis - 10-15 mg / kg for a long time, appoint children, given the weight of the child: for children weighing 25 - 50 kg, take 1 kaps. Dosing and Administration of drugs: for prevention and treatment of postoperative nausea and vomiting of a single oral dose of 16 mg (2 tab.) Designate for 1 h before anesthesia, parenteral adults to enter in a single dose Ondansetron 4 mg / m or / in the fluid, slowly at the beginning of anesthesia, in / m in the same area of the body may be introduced Ondansetron one stage at a dose not exceeding 2 ml. (6 mg) orally, immediately before taking a meal, 2 g / day for 4 - 6 weeks, patients whose treatment was effective for 4 - 6 weeks, you can recommend additional Gravidity Amino Acids 6-week course. day. Preparations bile acids. Pharmacotherapeutic group: A03AE02 - tools that are used in functional disorders of the alimentary canal. Pharmacotherapeutic group: A04AA03 - tools and Adult-Onset Diabetes Mellitus (Type 2 Diabetes) drugs that eliminate the nausea.